{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:55:20Z","timestamp":1791618920744,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Cross-disciplinary Research Fund of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine","award":["JYJC202413"],"award-info":[{"award-number":["JYJC202413"]}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["202402AA310073"],"award-info":[{"award-number":["202402AA310073"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01979-x","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:33:43Z","timestamp":1761899623000},"page":"5561-5573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leukocyte telomere length and risk of heart failure with preserved ejection fraction in high-risk Chinese patients with hypertension under 65\u00a0years"],"prefix":"10.1007","volume":"48","author":[{"given":"Alian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengde","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Chia Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3003-803X","authenticated-orcid":false,"given":"Huili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"1979_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2005.01.028","volume":"120","author":"DB Lombard","year":"2005","unstructured":"Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW. DNA repair, genome stability, and aging. Cell. 2005;120:497\u2013512. https:\/\/doi.org\/10.1016\/j.cell.2005.01.028.","journal-title":"Cell"},{"key":"1979_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nchembio.2007.38","volume":"3","author":"MA Blasco","year":"2007","unstructured":"Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol. 2007;3:640\u20139. https:\/\/doi.org\/10.1038\/nchembio.2007.38.","journal-title":"Nat Chem Biol"},{"key":"1979_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrg1656","volume":"6","author":"MA Blasco","year":"2005","unstructured":"Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6:611\u201322. https:\/\/doi.org\/10.1038\/nrg1656.","journal-title":"Nat Rev Genet"},{"key":"1979_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/gerona\/glq180","volume":"66","author":"KA Mather","year":"2011","unstructured":"Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci. 2011;66:202\u201313. https:\/\/doi.org\/10.1093\/gerona\/glq180.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1979_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","volume":"350","author":"EH Blackburn","year":"2015","unstructured":"Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350:1193\u20138. https:\/\/doi.org\/10.1126\/science.aab3389.","journal-title":"Science"},{"key":"1979_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxs008","volume":"35","author":"JL Sanders","year":"2013","unstructured":"Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35:112\u201331. https:\/\/doi.org\/10.1093\/epirev\/mxs008.","journal-title":"Epidemiol Rev"},{"key":"1979_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1158\/1055-9965.EPI-11-0005","volume":"20","author":"IM Wentzensen","year":"2011","unstructured":"Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011;20:1238\u201350. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0005.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1979_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020466","volume":"6","author":"H Ma","year":"2011","unstructured":"Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE. 2011;6:e20466. https:\/\/doi.org\/10.1371\/journal.pone.0020466.","journal-title":"PLoS ONE"},{"key":"1979_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079993","volume":"8","author":"J Zhao","year":"2013","unstructured":"Zhao J, Miao K, Wang H, Ding H, Wang DW. Association between telomere length and type 2 diabetes mellitus: a meta-analysis. PLoS ONE. 2013;8:e79993. https:\/\/doi.org\/10.1371\/journal.pone.0079993.","journal-title":"PLoS ONE"},{"key":"1979_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4227","volume":"349","author":"PC Haycock","year":"2014","unstructured":"Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2014;349:g4227. https:\/\/doi.org\/10.1136\/bmj.g4227.","journal-title":"BMJ"},{"key":"1979_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41588-021-00944-6","volume":"53","author":"V Codd","year":"2021","unstructured":"Codd V, Wang Q, Allara E, Musicha C, Kaptoge S, Stoma S, et al. Polygenic basis and biomedical consequences of telomere length variation. Nat Genet. 2021;53:1425\u201333. https:\/\/doi.org\/10.1038\/s41588-021-00944-6.","journal-title":"Nat Genet"},{"key":"1979_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/CIRCRESAHA.116.310517","volume":"121","author":"Y Zhan","year":"2017","unstructured":"Zhan Y, Karlsson IK, Karlsson R, Tillander A, Reynolds CA, Pedersen NL, et al. Exploring the causal pathway from telomere length to coronary heart disease: a network Mendelian randomization study. Circ Res. 2017;121:214\u20139. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.310517.","journal-title":"Circ Res"},{"key":"1979_CR13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.jacc.2007.01.027","volume":"49","author":"P van der Harst","year":"2007","unstructured":"van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol. 2007;49:1459\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2007.01.027.","journal-title":"J Am Coll Cardiol."},{"key":"1979_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/07853890903321567","volume":"42","author":"P van der Harst","year":"2010","unstructured":"van der Harst P, de Boer RA, Samani NJ, Wong LS, Huzen J, Codd V, et al. Telomere length and outcome in heart failure. Ann Med. 2010;42:36\u201344. https:\/\/doi.org\/10.3109\/07853890903321567.","journal-title":"Ann Med"},{"key":"1979_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/heartjnl-2020-318654","volume":"108","author":"SPR Romaine","year":"2022","unstructured":"Romaine SPR, Denniff M, Codd V, Nath M, Koekemoer A, Anker SD, et al. Telomere length is independently associated with all-cause mortality in chronic heart failure. Heart. 2022;108:124\u20139. https:\/\/doi.org\/10.1136\/heartjnl-2020-318654.","journal-title":"Heart"},{"key":"1979_CR16","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272\u201387. https:\/\/doi.org\/10.1093\/cvr\/cvac013.","journal-title":"Cardiovasc Res"},{"key":"1979_CR17","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40:3297\u2013317. https:\/\/doi.org\/10.1093\/eurheartj\/ehz641.","journal-title":"Eur Heart J"},{"key":"1979_CR18","doi-asserted-by":"publisher","unstructured":"Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019; 16(3):182\u2013241. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2019.03.014","DOI":"10.11909\/j.issn.1671-5411.2019.03.014"},{"key":"1979_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003.","journal-title":"J Am Soc Echocardiogr"},{"key":"1979_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14:591\u2013602. https:\/\/doi.org\/10.1038\/nrcardio.2017.65.","journal-title":"Nat Rev Cardiol"},{"key":"1979_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/CLEP.S253612","volume":"12","author":"MP Lee","year":"2020","unstructured":"Lee MP, Glynn RJ, Schneeweiss S, Lin KJ, Patorno E, Barberio J, et al. Risk factors for heart failure with preserved or reduced ejection fraction among Medicare beneficiaries: application of competing risks analysis and gradient boosted model. Clin Epidemiol. 2020;12:607\u201316. https:\/\/doi.org\/10.2147\/CLEP.S253612.","journal-title":"Clin Epidemiol"},{"key":"1979_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jacc.2019.05.052","volume":"74","author":"J Tromp","year":"2019","unstructured":"Tromp J, Shen L, Jhund PS, Anand IS, Carson PE, Desai AS, et al. Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. 2019;74:601\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2019.05.052.","journal-title":"J Am Coll Cardiol"},{"key":"1979_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrcardio.2013.30","volume":"10","author":"F Fyhrquist","year":"2013","unstructured":"Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol. 2013;10:274\u201383. https:\/\/doi.org\/10.1038\/nrcardio.2013.30.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1979_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/01.hyp.0000027280.91984.1b","volume":"40","author":"A Aviv","year":"2002","unstructured":"Aviv A. Chronology versus biology: telomeres, essential hypertension, and vascular aging. Hypertension. 2002;40(3):229\u201332. https:\/\/doi.org\/10.1161\/01.hyp.0000027280.91984.1b.","journal-title":"Hypertension"},{"issue":"2 Pt 2","key":"1979_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/01.hyp.37.2.381","volume":"37","author":"A Benetos","year":"2001","unstructured":"Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension. 2001;37(2 Pt 2):381\u20135. https:\/\/doi.org\/10.1161\/01.hyp.37.2.381.","journal-title":"Hypertension"},{"issue":"16\u201317","key":"1979_CR26","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.clinbiochem.2015.07.013","volume":"48","author":"L Ma","year":"2015","unstructured":"Ma L, Li Y, Wang J. Telomeres and essential hypertension. Clin Biochem. 2015;48(16\u201317):1195\u20139. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.013.","journal-title":"Clin Biochem"},{"issue":"11","key":"1979_CR27","doi-asserted-by":"publisher","first-page":"e024582","DOI":"10.1161\/JAHA.121.024582","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen X, Lin H, Xiong W, Pan J, Huang S, Xu S, et al. p53-dependent mitochondrial in heart failure with preserved ejection fraction. J Am Heart Assoc. 2022;11(11):e024582. https:\/\/doi.org\/10.1161\/JAHA.121.024582.","journal-title":"J Am Heart Assoc"},{"key":"1979_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/emboj\/cdg013","volume":"22","author":"A Leri","year":"2003","unstructured":"Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003;22:131\u20139. https:\/\/doi.org\/10.1093\/emboj\/cdg013.","journal-title":"EMBO J"},{"issue":"9","key":"1979_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005086","volume":"6","author":"M Sharifi-Sanjani","year":"2017","unstructured":"Sharifi-Sanjani M, Oyster NM, Tichy ED, Bedi KC Jr, Harel O, Margulies KB, et al. Cardiomyocyte-specific telomere shortening is a distinct signature of heart failure in humans. J Am Heart Assoc. 2017;6(9):e005086. https:\/\/doi.org\/10.1161\/JAHA.116.005086.","journal-title":"J Am Heart Assoc"},{"key":"1979_CR30","doi-asserted-by":"publisher","first-page":"10308","DOI":"10.1073\/pnas.191169098","volume":"98","author":"H Oh","year":"2021","unstructured":"Oh H, Taffet GE, Youker KA, Entman ML, Overbeek PA, Michael LH, et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A. 2021;98:10308\u201313. https:\/\/doi.org\/10.1073\/pnas.191169098.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1979_CR31","doi-asserted-by":"publisher","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, et al, EMPEROR-Preserved Trial Investigators. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451-61. https:\/\/doi.org\/10.1056\/NEJMoa2107038","DOI":"10.1056\/NEJMoa2107038"},{"key":"1979_CR32","doi-asserted-by":"publisher","unstructured":"Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al, DELIVER Trial Committees and Investigators. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089-98. https:\/\/doi.org\/10.1056\/NEJMoa2206286","DOI":"10.1056\/NEJMoa2206286"},{"key":"1979_CR33","doi-asserted-by":"publisher","unstructured":"Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, et al, PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. 2019;381(17):1609-20. https:\/\/doi.org\/10.1056\/NEJMoa1908655","DOI":"10.1056\/NEJMoa1908655"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01979-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:06:22Z","timestamp":1789398382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01979-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01979-x","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine Ethics Review Board (2016\u2013256-T191). Informed consent was obtained from all the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}